|
HY-121140-5mg
|
MedChemexpress LLC
|
AZ1729 [CAS 2016864-46-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-13438-10mg
|
MedChemexpress LLC
|
AZD3839 (free base) [CAS 1227163-84-9]
|
|
Cancer-programmed cell death
|
|
|
HY-13438-25mg
|
MedChemexpress LLC
|
AZD3839 (free base) [CAS 1227163-84-9]
|
|
Cancer-programmed cell death
|
|
|
HY-13438-5mg
|
MedChemexpress LLC
|
AZD3839 (free base) [CAS 1227163-84-9]
|
|
Cancer-programmed cell death
|
|
|
HY-13438-50mg
|
MedChemexpress LLC
|
AZD3839 (free base) [CAS 1227163-84-9]
|
|
Cancer-programmed cell death
|
|
|
HY-137440-1mg
|
MedChemexpress LLC
|
Firazorexton [CAS 2274802-95-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-137440-10mg
|
MedChemexpress LLC
|
Firazorexton [CAS 2274802-95-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-137440-5mg
|
MedChemexpress LLC
|
Firazorexton [CAS 2274802-95-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-137655A-1mg
|
MedChemexpress LLC
|
BMS-P5 (free base) [CAS 1550371-22-6]
|
|
Cancer-programmed cell death
|
|
|
HY-137655A-10mg
|
MedChemexpress LLC
|
BMS-P5 (free base) [CAS 1550371-22-6]
|
|
Cancer-programmed cell death
|
|
|
HY-137655A-25mg
|
MedChemexpress LLC
|
BMS-P5 (free base) [CAS 1550371-22-6]
|
|
Cancer-programmed cell death
|
|
|
HY-137655A-5mg
|
MedChemexpress LLC
|
BMS-P5 (free base) [CAS 1550371-22-6]
|
|
Cancer-programmed cell death
|
|
|
HY-137655A-50mg
|
MedChemexpress LLC
|
BMS-P5 (free base) [CAS 1550371-22-6]
|
|
Cancer-programmed cell death
|
|
|
HY-16040-10mg
|
MedChemexpress LLC
|
AM095 (free acid) [CAS 1228690-36-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-16040-100mg
|
MedChemexpress LLC
|
AM095 (free acid) [CAS 1228690-36-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-16040-200mg
|
MedChemexpress LLC
|
AM095 (free acid) [CAS 1228690-36-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-16040-5mg
|
MedChemexpress LLC
|
AM095 (free acid) [CAS 1228690-36-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-16040-50mg
|
MedChemexpress LLC
|
AM095 (free acid) [CAS 1228690-36-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-16040-500mg
|
MedChemexpress LLC
|
AM095 (free acid) [CAS 1228690-36-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-19995-10mg
|
MedChemexpress LLC
|
GSK137647A [CAS 349085-82-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-19995-100mg
|
MedChemexpress LLC
|
GSK137647A [CAS 349085-82-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-19995-25mg
|
MedChemexpress LLC
|
GSK137647A [CAS 349085-82-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-19995-5mg
|
MedChemexpress LLC
|
GSK137647A [CAS 349085-82-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-19995-50mg
|
MedChemexpress LLC
|
GSK137647A [CAS 349085-82-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-B1899-100mg
|
MedChemexpress LLC
|
Taurodeoxycholic acid [CAS 516-50-7]
|
|
|
|
